Quote | iCo Therapeutics (OTCMKTS:MSCLF)
Last: | $0.3956 |
---|---|
Change Percent: | 5.56% |
Open: | $0.38493 |
Close: | $0.3956 |
High: | $0.41 |
Low: | $0.38493 |
Volume: | 7,000 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | iCo Therapeutics (OTCMKTS:MSCLF)
–SAT-3247 treatment improved muscle repair and regeneration in canine model of DMD – SAT-3247 treatment also improved muscle force in this canine model of DMD – Satellos remains on track to initiate a Phase 1 clinical trial in Q3 2024 Satellos Bios...
– Frank Gleeson, Satellos CEO, to participate in a panel discussion titled "Research Row: PPMD Moving the Needle" on June 29, 2024 – Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSCL, OTCQB: MSCLF), a public biotech company d...
Message Board Posts | iCo Therapeutics (OTCMKTS:MSCLF)
Subject | By | Source | When |
---|---|---|---|
50m cash raised. Something brewing! | Oloo | investorshub | 04/20/2023 12:55:04 AM |
News on the go ! | Oloo | investorshub | 04/14/2022 2:28:13 PM |
On the way for a lead candidate: | Oloo | investorshub | 03/31/2022 4:53:10 PM |
Awesome thing coming soon ! | Oloo | investorshub | 12/14/2021 3:09:15 PM |
Effective Dec. 10,2021 ICOTF will change to MSCLF. | Renee | investorshub | 12/09/2021 3:04:03 PM |
News, Short Squeeze, Breakout and More Instantly...
–SAT-3247 treatment improved muscle repair and regeneration in canine model of DMD – SAT-3247 treatment also improved muscle force in this canine model of DMD – Satellos remains on track to initiate a Phase 1 clinical trial in Q3 2024 Satellos Bios...
– Frank Gleeson, Satellos CEO, to participate in a panel discussion titled "Research Row: PPMD Moving the Needle" on June 29, 2024 – Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSCL, OTCQB: MSCLF), a public biotech company d...
Satellos expects to begin first-in-human clinical trials mid-year for SAT-3247, an oral small molecule drug candidate in development as a novel regenerative medicine approach to treating DMD Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSC...